Content
Treatment
Resources that ensure the quality, access and availability of supports that can help individuals experiencing harms from opioid use.
Image / Video
Image
Body
Resources | Description | Organization |
|---|---|---|
| Traitement du trouble lié à l'utilisation d'opioïdes : une approche de collaboration interdisciplinaire (in French only) | Describes virtual training offered to professionals who are members of care teams that work with people who have an opioid-related disorder. | National Institute of Public Health in Quebec |
| Opioid Toolkit: Resources for Nurses and the Public | Opioid toolkit includes a variety of provincial and federal resources for nurses and the public. | Nurses Association of New Brunswick |
| Opioid Agonist Treatment (OAT) Clinics & Providers (Public Distribution) | List of opioid agonist treatment providers and clinics located in British Columbia’s Interior Health Authority. | Interior Health (British Columbia) |
| Minister's statement on select standing committee's recommendations | Statement from British Columbia’s Minister of Addictions and Mental Health, Sheila Malcolmson about the Special Committee on Health, which reaffirm the tools the government is using to address the overdose crisis and toxic drug supply. | British Columbia Ministry of Mental Health and Addictions |
| Buprenorphine for Opioid Use Disorder | Guide for patients on buprenorphine for opioid use disorder and their families. Provides general information about the medication, who it’s for and what to expect. | Nova Scotia Health |
| Approach to Patients With Opioid Use Disorder in the ED: Buprenorphine Standard Initiation | Poster for healthcare providers in ED. Using a flowchart, illustrates how to approach situations where a patient presents with opioid withdrawal, overdose or complication related to opioid use. | Meta PHI |
| O.A.T. | Poster describes different types of opioid agonist treatment (OAT) medication available in most jurisdictions to treat opioid use disorder. Foundry, British Columbia
| Foundry, British Columbia |
| Buprenorphine/Naloxone for Opioid Use Disorder: Your Questions Answered | Information sheet for people interested in or starting buprenorphine/naloxone. Provides information about what to expect, how to take it, monitoring and safe storage. | The Institute for Safe Medication Practices Canada |
| Opioid Use Disorder & You: Information for opioid users and their families and friends | PDF pamphlet for individuals with opioid use disorder (OUD) and their family and friends. Offers information about OUD and support services specific to people living in Alberta | Alberta Health Services |
| Opioid Withdrawal/Buprenorphine Initiation Order Set | Sample order set for clinicians starting patients on Buprenorphine | Meta PHI |
| Opioids | Information for healthcare professionals and stakeholders on some aspects of the province's response to opioid use and overdose. | Ontario Ministry of Health |
| Opioid use disorder: Beyond Stigma | Animated video explores the impacts of stigma on all aspects of treatment for people living with opioid use disorder and how we can work together to move beyond stigma. | Canadian Mental Health Association |
| Methadone | Fact sheet for the public. | Centre for Addiction and Mental Health |
| Administration of MMT - Tips for Ensuring Right Dose When Administering Methadone | Nursing best practice guideline for methadone maintenance treatment. | Registered Nurses' Association of Ontario |
| Opioid Safety Recommendations for Adult Palliative Medicine | Recommendations about opioid safety for adult palliative medicine | Canadian Society of Palliative Care Physicians |
| Opioid Agonist Therapy: Guidelines for Manitoba Pharmacists | Guidelines on the use of methadone and buprenorphine for OAT, with a brief discussion on the use of methadone for pain management. | College of Pharmacists of Manitoba |
| Approach to Patients With Opioid Use Disorder in the ED | Decision aid for treatment pathways. | META PHI |
| Analgésiques opioïdes à courte action : Informations pour les patients et les familles (in French only) | Information for patients on the use of short-term opioids to manage pain and reduce side effects and harms. | CHU Sainte-Justine |
| Les opioïdes : guide de référence pour les psychologues praticiens (in French only) | French translation and Quebec contextualization of the American Psychological Association’s The Opioid Guide: A Resource Guide for Practicing Psychologists. | Ordre des psychologues du Québec |
| Pharmaceutical Alternatives and Opioid Agonist Therapy: Community Considerations | Provides key areas to consider when supporting individuals with opioid use disorder who are living in rural and remote communities: | First Nations Health Authority |
| Guide to Chronic (Non-Cancer/Non-Palliative) Pain Management with Patients Already on Opioid Therapy | Guide for family medicine residents. | College of Family Physicians of Canada |
| Key takeaways from pharmacists as opioid stewards: a showcase of the evidence | Important messages from a webinar series for pharmacists about opioids and links to the webinars. | Canadian Pharmacists Association |
| Practice Standard Safe Prescribing of Opioids and Sedatives | Prescribing guidance from the professional body. | College of Physicians and Surgeons of British Columbia |
| Opioid safety for patients with chronic pain | Information sheet for patients prescribed opioids for chronic pain. | Alberta College of Pharmacists |
| ODPRN suggested calculation of opioid milligrams of morphine equivalents | Provides standardized measures of the total amount of opioid dispensed to allow for comparison, safe combining and prescribing of opioids. | Ontario Drug Policy Research Network |
| Impact of the Overdose Crisis on Chronic Pain Sufferers | Issues brief on opioids and pain management for nurses and nurse practitioners. | Nurses and Nurse Practitioners of British Columbia |
| Treating opioid dependence with medication: methadone | Information sheet for clients and patients who are prescribed methadone. | Centre hospitalier de l’Université de Montréal |
| Treating opioid dependence with medication: buprenorphine/naloxone | Information sheet for clients and patients who are prescribed buprenorphine/naloxone. | Centre hospitalier de l’Université de Montréal |
| Methadone for Analgesia Practice Standards and Guidelines | A resource for physicians who prescribe methadone for the management of pain. | College of Physicians and Surgeons of Saskatchewan |
| A guide to the use of depot buprenorphine | Evidence-based information for prescribers on the effectiveness, use, contraindications and prescribing of 28-day depot buprenorphine injection. | Meta PHI |
| Opiate Overdose 2.1 | Treatment protocol and information about opioids and naloxone administration for healthcare providers. | Alberta Health Services |
| Healing the Whole Human Being | Knowledge synthesis focusing on what makes interventions for the prevention and treatment of opioid dependency work in Indigenous contexts. Of particular interest are non-pharmacochemical wrap-around models. | Alberta First Nations Information Governance Centre |
| Prescribing Standards for Nurse Practitioners | Document outlining expectations for safe nurse practitioner prescribing, including professional responsibilities and accountabilities, restrictions to prescribing, legal obligations and requirements for managing opioid use disorder. | College and Association of Registered Nurses of Alberta |
| Buprenorphine-Naloxone (Suboxone®) | Information sheet for patients. | Vancouver Coastal Health and Providence Health Care |
| Perinatal Substance Use | Learning module for healthcare practitioners to provide education and support for evidence-based, patient-centred, trauma-informed and culturally-safe care for a pregnant person who experiences substance use and for a newborn exposed to substances during pregnancy. | University of British Columbia, Continuing Professional Development, Faculty of Medicine |
| Care of the Newborn Exposed to Substances During Pregnancy | A manual for the perinatal substance use learning module for healthcare practitioners. | Perinatal Services BC |
| Injectable Opioid Agonist Treatment (iOAT): Snapshots and Compendium of Resources | Resources to assist provincial governments and health authorities in determining whether supervised injectable opioid agonist treatment programs should be expanded in Ontario, along with documentation of system level processes necessary for successful implementation. | Addictions and Mental Health Ontario |
| Summary Safety Review – Methadone-Containing Products Used to Treat Opioid Dependence – Assessing the Potential Risk of Lack of Effect when Switching between Different Products | Safety bulletin about methadone prescribing. | Neighbourhood Pharmacy Association of Canada |
| Guideline for the Treatment of Opioid Neurotoxicity | Guidelines for addressing opioid neurotoxicity in palliative care. | Alberta Health Services |
| Le traitement du trouble lié à l’utilisation d’opioïdes (TUO) | OAT Guidelines for Quebec physicians. (in French only) | Collège des médecins du Québec |
| A Rapid Review of Opioid Substitution Therapy During Major Disruptions to Medical Care | Describes the challenges and potential solutions to disruptions in treatment. | Canadian Institutes of Health Research |
| Injectable Opioid Agonist Treatment for Patients with Opioid Dependence: A Review of Clinical and Cost-Effectiveness | Evidence summary of the clinical effectiveness and cost effectiveness of injectable opioid agonist treatment, compared with alternative pharmacological treatments or no treatment, for individuals with opioid dependency. | Canadian Agency for Drugs and Technologies in Health |
| Managing opioid use disorder in primary care | This simplified guideline for managing opioid use disorder was developed with a primary care focus. Recommendations are accompanied by practice pearls and additional resources to support primary care practitioners and shared, informed decision making with patients. | Canadian Family Physician |
| Opioid Agonist Therapy: Community Considerations | Presents some key areas to consider when supporting Indigenous individuals with opioid use disorder who are living in rural and remote communities. | First Nations Health Authority |
| Opioid Agonist Therapy (OAT) Standards | The opioid agonist therapy (OAT) standards define the minimum acceptable level of care in Saskatchewan to ensure patient safety for the dispensing of opioid agonist therapies for the treatment of opioid use disorders. | Saskatchewan College of Pharmacy Professionals |
| Exploring Expanded Response Options to Opioid Harms: Case Studies from Four Canadian Clinics | Case studies with four Canadian primary care providers who offer responses to opioid harms that extend beyond those outlined in the guidelines of the Canadian Research Initiative in Substance Misuse. The report suggests that access to pharmaceutical opioid options could substantially improve quality of care and quality of life among people who use opioids. | Canadian Centre on Substance Use and Addiction |
| Opioid Use Disorder Primary Care Pathway | Two-page support for prescribers making decisions on medication choice, treatment considerations, dosage and symptom management. | Alberta College of Family Physicians |
| Opioid Agonist Treatment Assessment Criteria | Outlines the opioid agonist treatment assessment criteria that are used by community operations advisors when conducting a community pharmacy assessment of a pharmacy that provides opioid agonist treatment. | Ontario College of Pharmacists |
| Opioid Agonist Treatment, General Information | Description of opioid agonist treatment purpose and context, and the medications and prescribing practices used to administer it. | British Columbia Centre on Substance Use |
| Opioid Dependence Treatment (ODT) Core Course | A course to prepare learners to effectively and safely manage the treatment of clients receiving methadone or buprenorphine for opioid use disorder. | Centre for Addiction and Mental Health |
| Safe and Effective Use of Opioids for Chronic Non-cancer Pain (training) | An online course providing healthcare workers with evidence-based tools and recommendations and guiding them through a point-of-care tool. | Centre for Addiction and Mental Health |
| Programs for the Treatment of Opioid Addiction: An Environmental Scan | Environmental scan describing opioid addiction treatment programs in Canada and internationally, including their wait times and patient characteristics. | Canadian Agency for Drugs and Technologies in Health |
| Opioids Survivors Guide | A handbook about treatment and opioid agonist therapy written by people with lived and living experience using opioid and other street drugs. | British Columbia Centre on Substance Use |
| Injectable Opioid Agonist Treatment Guideline | The first national injectable opioid agonist treatment guideline, including a clinical guideline and an operational guidance document. | Canadian Research Initiative in Substance Misuse |
| Opioid Training for Healthcare Providers Course Catalogue | An environmental scan for healthcare providers outlining the training programs available to initiate and maintain treatment of opioid use disorder. | Mental Health Commission of Canada |
| Opioids Clinical Primer | Online courses to support clinician management of individuals living with chronic pain and/or opioid use disorder, including topics such as connections with mental health, non-pharmacological pain management and safer opioid prescribing. | MacHealth |
| Opioid Use Disorder Tool | An online tool that provides primary care providers with detailed guidance on identifying, and managing individuals living with an opioid use disorder, including approaches for buprenorphine-naloxone induction. | Centre for Effective Practice |
| Best Practices across the Continuum of Care for the Treatment of Opioid Use Disorder | Outlines the evidence for the various components in the continuum of care for the treatment of opioid use disorder, including principles for the manner in which services should be delivered, and highlights the actions taking place across Canada to respond to the opioid crisis. | Canadian Centre on Substance Use and Addiction |
| Treatment of Opioid Use Disorder during Pregnancy | Supplement that emphasize developmentally appropriate, youth-centred, trauma-informed, culturally appropriate care for youth. | British Columbia Centre on Substance Use |
| Treatment of Opioid Use Disorder for Youth | Supplement that emphasize developmentally appropriate, youth-centred, trauma-informed, culturally appropriate care for youth. | British Columbia Centre on Substance Use |
| Management of opioid use disorders: A national clinical practice guideline | Outlines optimal treatment approaches and the strength of the evidence behind the recommendations | Canadian Research Initiative in Substance Misuse |
| Care pathways | Care pathways to guide treatment for prescription drug harms | Canadian Centre on Substance Use and Addiction |
| Management of Infants Born to Mothers Who Have Used Opioid During Pregnancy | Practice point that focuses on the effects of opioid withdrawal and current management strategies in the care of infants born to mothers with opioid dependency | Canadian Paediatric Society |
| Opioid Prescribing for Acute Pain: Patient Reference Guide and Clinical Guide | Quality standard that addresses care for people 16 years of age and older (including those who are pregnant) who have or are suspected of having opioid use disorder | Health Quality Ontario |
| Clinical Resource Guide for the Management of Acute Substance Withdrawal | Provides evidence-based approaches to support and care for youth through substance withdrawal. | Hamilton Health Sciences |
| Urine Drug Testing in Patients Prescribed Opioid Agonist Treatment | Guidance on urine drug testing in the clinical management of opioid use disorder. | BCCSU |
| Recommendations for the provision of opioid agonist therapy in publicly funded residential addiction treatment centres in Ontario | Guidance on OAT for Ontario residential treatment centres. | META:PHI |
| Methadone treatment for patients who use fentanyl: Plain language summary | Guidance for prescribers. | META:PHI |
| Buprenorphine | Fact sheet for the public. | Centre for Addiction and Mental Health |
| Opioid Addiction | Fact sheet for the public. | Centre for Addiction and Mental Health |
| Heroin | Fact sheet for the public. | Centre for Addiction and Mental Health |
| Opioid Use and Opioid Use Disorder Education Resource | Education modules for students and faculty in social work, pharmacy and registered nursing programs. | Canadian Association of Schools of Nursing |
